These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5915585)

  • 1. Corticosteroid-induced dwarfism in Still's disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in two cases.
    Ward DJ; Hartog M; Ansell BM
    Ann Rheum Dis; 1966 Sep; 25(5):416-21. PubMed ID: 5915585
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on hydroxyproline excretion and corticosteroid-induced dwarfism: treatment with human growth hormone.
    Matiasevic D; Gershberg H
    Metabolism; 1966 Aug; 15(8):720-9. PubMed ID: 5974906
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticotrophin therapy in juvenile chronic polyarthritis (Still's disease) and effect on growth.
    Zutshi DW; Friedman M; Ansell BM
    Arch Dis Child; 1971 Oct; 46(249):584-93. PubMed ID: 4330191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary hydroxyproline excretion in patients with juvenile rheuatoid arthritis, with and without corticosteroid therapy.
    Smith M; Ansell BM; Bywaters EG
    J Pediatr; 1968 Dec; 73(6):875-81. PubMed ID: 4880147
    [No Abstract]   [Full Text] [Related]  

  • 5. Cortisol and growth hormone secretion in relation to linear growth: patients with Still's disease on different therapeutic regimens.
    Sturge RA; Beardwell C; Hartog M; Wright D; Ansell BM
    Br Med J; 1970 Sep; 3(5722):547-51. PubMed ID: 4318282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of human growth hormone in corticosteroid-treated children.
    Morris HG; Jorgensen JR; Elrick H; Goldsmith RE
    J Clin Invest; 1968 Mar; 47(3):436-51. PubMed ID: 5637134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary hydroxyproline in children with growth hormone deficiency. Clinical value in diagnosis and prognosis.
    Wharton BA; Brown G; Raynor PH; Howells G; Pennock CA
    Arch Dis Child; 1974 Feb; 49(2):159-62. PubMed ID: 4817449
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis and growth retardation in children: treatment with human growth hormone.
    Butenandt O
    Eur J Pediatr; 1979 Jan; 130(1):15-28. PubMed ID: 759180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyproline excretion in various forms of growth failure.
    Teller WM; Genscher U; Burkhardt H; Rommel K
    Arch Dis Child; 1973 Feb; 48(2):127-32. PubMed ID: 4690509
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth in Still's disease.
    Lancet; 1971 Nov; 2(7735):1188-9. PubMed ID: 4107988
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyproline excretion in pituitary dwarfs treated with therapeutic doses of human growth hormone.
    Batrinos ML; Grispos GE; Papadopoulou ZP; Varonos DD
    Horm Res; 1973; 4(5):311-20. PubMed ID: 4755421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of growth retardation in children with rheumatoid arthritis and still's disease: a clinical investigation (author's transl)].
    Sänger L
    Monatsschr Kinderheilkd (1902); 1974 Jun; 122(6):331-6. PubMed ID: 4368105
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of growth hormone on hydroxyprolinuria in patients with pituitary dwarfism].
    Kopecký A
    Endokrinologie; 1971; 57(2):194-200. PubMed ID: 5546127
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ascorbic acid on urinary hydroxyproline of children receiving corticosteroids.
    Saphykhajon P; Grossman BJ; Quinn J
    Arch Dis Child; 1977 Jan; 52(1):82. PubMed ID: 836059
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe restrictive pulmonary defect in a patient with adult-onset Still's disease.
    Cantor JP; Pitcher WD; Hurd E
    Chest; 1987 Nov; 92(5):939-40. PubMed ID: 3665615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone studies in patients with rheumatoid arthritis with or without glucocorticoid therapy.
    Butenandt O; Kelch A; Rajmann E
    Z Kinderheilkd; 1974; 118(1):53-62. PubMed ID: 4372817
    [No Abstract]   [Full Text] [Related]  

  • 17. Dwarfism with elevated levels of plasma growth hormone.
    Najjar SS; Khachadurian AK; Ilbawi MN; Blizzard RM
    N Engl J Med; 1971 Apr; 284(15):809-12. PubMed ID: 5549802
    [No Abstract]   [Full Text] [Related]  

  • 18. Still's disease associated with Coxsackie infection and haemophagocytic syndrome.
    Heaton DC; Moller PW
    Ann Rheum Dis; 1985 May; 44(5):341-4. PubMed ID: 2988465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile and adult systemic-onset Still's disease.
    Lancet; 1990 Jul; 336(8707):92. PubMed ID: 1975330
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality and prognosis related to the amyloidosis of Still's disease.
    Smith ME; Ansell BM; Bywaters EG
    Ann Rheum Dis; 1968 Mar; 27(2):137-45. PubMed ID: 5646432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.